Truncated human endothelin receptor A produced by alternative splicing and its expression in melanoma
1998

Truncated Endothelin Receptor A in Melanoma

Sample size: 5 publication Evidence: moderate

Author Information

Author(s): YF Zhang, S Jeffery, SA Burchill, PA Berry, JC Kaski, ND Carter

Primary Institution: St George's Hospital Medical School

Hypothesis

The study aimed to detect endothelin receptor variants using molecular strategies.

Conclusion

A truncated human ETA receptor with exons 3 and 4 skipped has been found in melanoma cell lines and tissues, resulting in loss of binding affinity for its ligand, ET-1.

Supporting Evidence

  • The truncated receptor was expressed in all tissues and cells examined, but the level of expression varied.
  • In melanoma cell lines and tissues, the truncated receptor gene was the major species.
  • A 1.9-kb ETA transcript was identified in melanoma cell lines, which was much smaller than the transcript in other tissues.
  • The truncated ETA receptor-transfected CHO cells did not show binding affinity to endothelin 1 or endothelin 3.
  • Both wild-type and truncated ETA receptors were expressed in many normal tissues, but the truncated form was dominant in melanoma.

Takeaway

Researchers found a shorter version of a receptor in melanoma that doesn't work like the normal one, which might change how cells respond to certain signals.

Methodology

Reverse transcriptase polymerase chain reaction (RT-PCR) was used to amplify human endothelin receptor A and ETB receptor mRNA.

Limitations

The function and biological significance of the truncated ETA receptor are not clear.

Participant Demographics

Melanoma tissues from different patients and normal human tissues.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication